226 related articles for article (PubMed ID: 14514131)
1. Risk of malignancy in an unselected cohort of Icelandic patients with systemic lupus erythematosus.
Ragnarsson O; Gröndal G; Steinsson K
Lupus; 2003; 12(9):687-91. PubMed ID: 14514131
[TBL] [Abstract][Full Text] [Related]
2. High incidence of potentially virus-induced malignancies in systemic lupus erythematosus: a long-term followup study in a Danish cohort.
Dreyer L; Faurschou M; Mogensen M; Jacobsen S
Arthritis Rheum; 2011 Oct; 63(10):3032-7. PubMed ID: 21953088
[TBL] [Abstract][Full Text] [Related]
3. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
4. An international cohort study of cancer in systemic lupus erythematosus.
Bernatsky S; Boivin JF; Joseph L; Rajan R; Zoma A; Manzi S; Ginzler E; Urowitz M; Gladman D; Fortin PR; Petri M; Edworthy S; Barr S; Gordon C; Bae SC; Sibley J; Isenberg D; Rahman A; Aranow C; Dooley MA; Steinsson K; Nived O; Sturfelt G; Alarcón G; Senécal JL; Zummer M; Hanly J; Ensworth S; Pope J; El-Gabalawy H; McCarthy T; St Pierre Y; Ramsey-Goldman R; Clarke A
Arthritis Rheum; 2005 May; 52(5):1481-90. PubMed ID: 15880596
[TBL] [Abstract][Full Text] [Related]
5. The age-risk relationship of haematologic malignancies in female patients with systemic lupus erythematosus: a nationwide retrospective cohort study.
Lin YC; Yen JH; Chang SJ; Lin YC
Lupus; 2012 Oct; 21(11):1250-6. PubMed ID: 22740427
[TBL] [Abstract][Full Text] [Related]
6. Increased cancer risk in patients with cutaneous lupus erythematosus and systemic lupus erythematosus compared with the general population: A Danish nationwide cohort study.
Westermann R; Zobbe K; Cordtz R; Haugaard JH; Dreyer L
Lupus; 2021 Apr; 30(5):752-761. PubMed ID: 33497306
[TBL] [Abstract][Full Text] [Related]
7. Systemic lupus erythematosus and the risk of malignancy.
Cibere J; Sibley J; Haga M
Lupus; 2001; 10(6):394-400. PubMed ID: 11434573
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of malignancy in patients with systemic lupus erythematosus.
Ramsey-Goldman R; Mattai SA; Schilling E; Chiu YL; Alo CJ; Howe HL; Manzi S
J Investig Med; 1998 Jun; 46(5):217-22. PubMed ID: 9676054
[TBL] [Abstract][Full Text] [Related]
9. Incidence of cancer in a cohort of Spanish patients with systemic lupus erythematosus.
Hidalgo-Conde A; de Haro Liger M; Abarca-Costalago M; Álvarez Pérez M; Valdivielso-Felices P; González-Santos P; Fernández-Nebro A
Reumatol Clin; 2013; 9(6):359-64. PubMed ID: 24099959
[TBL] [Abstract][Full Text] [Related]
10. Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden.
Grönhagen CM; Fored CM; Granath F; Nyberg F
Br J Dermatol; 2011 Jun; 164(6):1335-41. PubMed ID: 21574972
[TBL] [Abstract][Full Text] [Related]
11. Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study.
Azrielant S; Tiosano S; Watad A; Mahroum N; Whitby A; Comaneshter D; Cohen AD; Amital H
Immunol Res; 2017 Apr; 65(2):464-469. PubMed ID: 28091805
[TBL] [Abstract][Full Text] [Related]
12. Risks, subtypes, and hospitalization costs of stroke among patients with systemic lupus erythematosus: a retrospective cohort study in Taiwan.
Wang IK; Muo CH; Chang YC; Liang CC; Lin SY; Chang CT; Yen TH; Chuang FR; Chen PC; Huang CC; Sung FC
J Rheumatol; 2012 Aug; 39(8):1611-8. PubMed ID: 22753653
[TBL] [Abstract][Full Text] [Related]
13. Risk of sudden sensorineural hearing loss in patients with systemic lupus erythematosus: a population-based cohort study.
Lin C; Lin SW; Weng SF; Lin YS
Audiol Neurootol; 2013; 18(2):95-100. PubMed ID: 23257626
[TBL] [Abstract][Full Text] [Related]
14. Cancer risk in a cohort of patients with systemic lupus erythematosus (SLE) in California.
Parikh-Patel A; White RH; Allen M; Cress R
Cancer Causes Control; 2008 Oct; 19(8):887-94. PubMed ID: 18386139
[TBL] [Abstract][Full Text] [Related]
15. Malignancy in systemic lupus erythematosus.
Abu-Shakra M; Gladman DD; Urowitz MB
Arthritis Rheum; 1996 Jun; 39(6):1050-4. PubMed ID: 8651970
[TBL] [Abstract][Full Text] [Related]
16. Malignancies among newly diagnosed systemic lupus erythematosus patients and their survival.
Kariniemi S; Rantalaiho V; Virta LJ; Kautiainen H; Puolakka K; Elfving P
Lupus; 2022 Dec; 31(14):1750-1758. PubMed ID: 36200539
[TBL] [Abstract][Full Text] [Related]
17. Is there an association of malignancy with systemic lupus erythematosus? An analysis of 276 patients under long-term review.
Sultan SM; Ioannou Y; Isenberg DA
Rheumatology (Oxford); 2000 Oct; 39(10):1147-52. PubMed ID: 11035137
[TBL] [Abstract][Full Text] [Related]
18. Malignancy in Pediatric-onset Systemic Lupus Erythematosus.
Bernatsky S; Clarke AE; Zahedi Niaki O; Labrecque J; Schanberg LE; Silverman ED; Hayward K; Imundo L; Brunner HI; Haines KA; Cron RQ; Oen K; Wagner-Weiner L; Rosenberg AM; O'Neil KM; Duffy CM; von Scheven E; Joseph L; Lee JL; Ramsey-Goldman R
J Rheumatol; 2017 Oct; 44(10):1484-1486. PubMed ID: 28765255
[TBL] [Abstract][Full Text] [Related]
19. Systemic lupus erythematosus in Iceland 1975 through 1984. A nationwide epidemiological study in an unselected population.
Gudmundsson S; Steinsson K
J Rheumatol; 1990 Sep; 17(9):1162-7. PubMed ID: 2290155
[TBL] [Abstract][Full Text] [Related]
20. Increased incidence of cancer in systemic lupus erythematosus: a Finnish cohort study with more than 25 years of follow-up.
Tallbacka KR; Pettersson T; Pukkala E
Scand J Rheumatol; 2018 Nov; 47(6):461-464. PubMed ID: 29318934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]